Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array.
Di Marco M, Astolfi A, Grassi E, Vecchiarelli S, Macchini M, Indio V, Casadei R, Ricci C, D'Ambra M, Taffurelli G, Serra C, Ercolani G, Santini D, D'Errico A, Pinna AD, Minni F, Durante S, Martella LR, Biasco G. Di Marco M, et al. Among authors: grassi e. Mol Med Rep. 2015 Nov;12(5):7479-84. doi: 10.3892/mmr.2015.4344. Epub 2015 Sep 22. Mol Med Rep. 2015. PMID: 26397140
State of the art biological therapies in pancreatic cancer.
Di Marco M, Grassi E, Durante S, Vecchiarelli S, Palloni A, Macchini M, Casadei R, Ricci C, Panzacchi R, Santini D, Biasco G. Di Marco M, et al. Among authors: grassi e. World J Gastrointest Oncol. 2016 Jan 15;8(1):55-66. doi: 10.4251/wjgo.v8.i1.55. World J Gastrointest Oncol. 2016. PMID: 26798437 Free PMC article. Review.
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression.
Durante S, Vecchiarelli S, Astolfi A, Grassi E, Casadei R, Santini D, Panzacchi R, Ricci C, Serravalle S, Tarantino G, Falconi M, Teti G, Indio V, Pession A, Minni F, Biasco G, Di Marco M. Durante S, et al. Among authors: grassi e. Oncotarget. 2016 Nov 15;7(46):74797-74806. doi: 10.18632/oncotarget.11501. Oncotarget. 2016. PMID: 27566563 Free PMC article.
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis.
Grassi E, Durante S, Astolfi A, Tarantino G, Indio V, Freier E, Vecchiarelli S, Ricci C, Casadei R, Formica F, Filippini D, Comito F, Serra C, Santini D, D' Errico A, Minni F, Biasco G, Di Marco M. Grassi E, et al. Int J Oncol. 2018 Jun;52(6):1972-1980. doi: 10.3892/ijo.2018.4344. Epub 2018 Mar 29. Int J Oncol. 2018. PMID: 29620163
Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1).
Arcelli A, Guido A, Buwenge M, Simoni N, Mazzarotto R, Macchia G, Deodato F, Cilla S, Bonomo P, Scotti V, Belgioia L, Tolento G, Cellini F, Grassi E, DI Marco M, Casadei R, Morganti AG, Cammelli S. Arcelli A, et al. Among authors: grassi e. Anticancer Res. 2020 Jan;40(1):465-472. doi: 10.21873/anticanres.13975. Anticancer Res. 2020. PMID: 31892602
285 results